Par Drugs and Chemicals Limited (NSE:PAR)
92.89
+2.72 (3.02%)
Mar 10, 2026, 11:43 AM IST
Par Drugs and Chemicals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,110 | 1,045 | 2,651 | 1,723 | 1,966 | 762 | Upgrade
|
| Market Cap Growth | -42.65% | -60.58% | 53.89% | -12.36% | 158.08% | 293.02% | Upgrade
|
| Enterprise Value | 771 | 857 | 2,352 | 1,565 | 1,826 | 673 | Upgrade
|
| Last Close Price | 90.17 | 84.93 | 215.45 | 140.00 | 159.75 | 61.49 | Upgrade
|
| PE Ratio | 7.98 | 7.82 | 18.28 | 15.20 | 21.34 | 6.56 | Upgrade
|
| PS Ratio | 1.04 | 1.03 | 2.77 | 1.80 | 2.62 | 1.25 | Upgrade
|
| PB Ratio | 1.04 | 1.06 | 3.10 | 2.42 | 3.28 | 1.46 | Upgrade
|
| P/TBV Ratio | 1.04 | 1.06 | 3.10 | 2.42 | 3.28 | 1.46 | Upgrade
|
| P/FCF Ratio | - | 7.00 | 18.71 | 29.99 | 44.54 | 10.83 | Upgrade
|
| P/OCF Ratio | - | 6.47 | 13.09 | 12.88 | 25.81 | 6.30 | Upgrade
|
| EV/Sales Ratio | 0.72 | 0.85 | 2.46 | 1.64 | 2.43 | 1.11 | Upgrade
|
| EV/EBITDA Ratio | 4.23 | 4.39 | 10.31 | 8.60 | 11.24 | 4.20 | Upgrade
|
| EV/EBIT Ratio | 5.34 | 5.40 | 12.14 | 10.45 | 14.08 | 5.10 | Upgrade
|
| EV/FCF Ratio | - | 5.74 | 16.60 | 27.25 | 41.38 | 9.56 | Upgrade
|
| Debt / Equity Ratio | - | - | - | - | - | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 0.52 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 1.18 | Upgrade
|
| Net Debt / Equity Ratio | -0.32 | -0.28 | -0.43 | -0.31 | -0.27 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.86 | -1.41 | -1.61 | -1.22 | -1.00 | -0.80 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.85 | -2.59 | -3.87 | -3.67 | -1.82 | Upgrade
|
| Asset Turnover | - | 0.91 | 1.00 | 1.14 | 0.97 | 0.89 | Upgrade
|
| Inventory Turnover | - | 7.38 | 6.67 | 7.15 | 6.25 | 6.10 | Upgrade
|
| Quick Ratio | - | 2.67 | 4.05 | 2.80 | 2.34 | 2.11 | Upgrade
|
| Current Ratio | - | 3.31 | 4.79 | 3.53 | 2.93 | 2.58 | Upgrade
|
| Return on Equity (ROE) | - | 14.47% | 18.49% | 17.29% | 16.44% | 25.02% | Upgrade
|
| Return on Assets (ROA) | - | 8.97% | 12.72% | 11.17% | 10.46% | 12.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.75% | 19.64% | 29.40% | 24.29% | 22.66% | 26.46% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 15.40% | 21.70% | 20.00% | 20.30% | 21.80% | Upgrade
|
| Earnings Yield | 12.53% | 12.78% | 5.47% | 6.58% | 4.69% | 15.25% | Upgrade
|
| FCF Yield | - | 14.29% | 5.34% | 3.33% | 2.25% | 9.24% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.78% | - | Upgrade
|
| Payout Ratio | - | - | - | - | 16.61% | 6.62% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.05% | - | - | - | 0.78% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.